• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

**标题**:修饰伊来霉素衍生物的全合成及生物评价

Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives.

机构信息

Organic Chemistry, Saarland University, Campus Building C4.2, 66123 Saarbruecken, Germany.

Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH Alliance, Im Neuenheimer Feld 282, 69120 Heidelberg, Germany.

出版信息

Mar Drugs. 2022 Oct 3;20(10):632. doi: 10.3390/md20100632.

DOI:10.3390/md20100632
PMID:36286456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9605216/
Abstract

Ilamycins/rufomycins are marine cycloheptapeptides containing unusual amino acids. Produced by sp., these compounds show potent activity against a range of mycobacteria, including multidrug-resistant strains of . The cyclic peptides target the AAA+ protein ClpC1 that, together with the peptidases ClpP1/ClpP2, forms an essential ATP-driven protease. Derivatives of the ilamycins with a simplified tryptophane unit are synthesized in a straightforward manner. The ilamycin derivative with a cyclic hemiaminal structure is active in the nM-range against several mycobacterial strains and shows no significant cytotoxicity. In contrast, derivative , with a glutamic acid at this position, is significantly less active, with MICs in the mid µM-range. Detailed investigations of the mode of action of indicate that deregulates ClpC1 activity and strongly enhances ClpC1-WT ATPase activity. The consequences of on ClpC1 proteolytic activities were substrate-specific, suggesting dual effects of on ClpC1-WT function. The positive effect relates to ClpC1-WT ATPase activation, and the negative to competition with substrates for binding to the ClpC1 NTD.

摘要

伊拉菌素/鲁福霉素是含有特殊氨基酸的海洋环七肽。这些化合物由 产生,对多种分枝杆菌具有很强的活性,包括耐多药的 。环状肽靶向 AAA+蛋白 ClpC1,它与肽酶 ClpP1/ClpP2 一起形成一种必需的 ATP 驱动蛋白酶。伊拉霉素的简化色氨酸单元的衍生物以简单的方式合成。具有环状亚氨基结构的伊拉霉素衍生物 在纳摩尔范围内对几种分枝杆菌菌株有效,且没有明显的细胞毒性。相比之下,该位置带有谷氨酸的衍生物 则活性显著降低,MIC 值在中微摩尔范围内。对 的作用模式的详细研究表明, 使 ClpC1 失活,并强烈增强 ClpC1-WT ATP 酶活性。 对 ClpC1 蛋白水解活性的影响具有底物特异性,表明 对 ClpC1-WT 功能具有双重影响。积极的影响与 ClpC1-WT ATP 酶的激活有关,而消极的影响则与与 ClpC1 NTD 结合的底物竞争有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/ed9da94f70b0/marinedrugs-20-00632-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/a96a62568cfb/marinedrugs-20-00632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/c35464217d97/marinedrugs-20-00632-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/9aad47d5e120/marinedrugs-20-00632-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/bff1834c9962/marinedrugs-20-00632-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/5eaf80dcdfae/marinedrugs-20-00632-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/f3df100db02c/marinedrugs-20-00632-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/13e5abcaf016/marinedrugs-20-00632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/ed9da94f70b0/marinedrugs-20-00632-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/a96a62568cfb/marinedrugs-20-00632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/c35464217d97/marinedrugs-20-00632-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/9aad47d5e120/marinedrugs-20-00632-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/bff1834c9962/marinedrugs-20-00632-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/5eaf80dcdfae/marinedrugs-20-00632-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/f3df100db02c/marinedrugs-20-00632-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/13e5abcaf016/marinedrugs-20-00632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/9605216/ed9da94f70b0/marinedrugs-20-00632-g003.jpg

相似文献

1
Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives.**标题**:修饰伊来霉素衍生物的全合成及生物评价
Mar Drugs. 2022 Oct 3;20(10):632. doi: 10.3390/md20100632.
2
Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity.近期关于伊拉霉素/红霉胺和环马菌素,以及具有抗疟疾和抗结核活性的海洋环肽的合成和生物活性的研究进展。
Mar Drugs. 2021 Aug 3;19(8):446. doi: 10.3390/md19080446.
3
Identification of the inhibitory mechanism of ecumicin and rufomycin 4-7 on the proteolytic activity of Mycobacterium tuberculosis ClpC1/ClpP1/ClpP2 complex.鉴定依克米辛和罗呋木霉素 4-7 对结核分枝杆菌 ClpC1/ClpP1/ClpP2 复合物蛋白水解活性的抑制机制。
Tuberculosis (Edinb). 2023 Jan;138:102298. doi: 10.1016/j.tube.2022.102298. Epub 2022 Dec 24.
4
The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring.结核分枝杆菌的活性 ClpP 蛋白酶是一种由七聚体 ClpP1 和 ClpP2 环组成的复合物。
EMBO J. 2012 Mar 21;31(6):1529-41. doi: 10.1038/emboj.2012.5. Epub 2012 Jan 27.
5
Metabolites from (VTCC43181) and Their Inhibition of ClpC1 Protein.(VTCC43181)的代谢产物及其对 ClpC1 蛋白的抑制作用。
Molecules. 2024 Feb 4;29(3):720. doi: 10.3390/molecules29030720.
6
Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions.ClpC1 N 端结构域与抗结核天然产物埃卡霉素复合物的结构揭示了独特的结合相互作用。
Acta Crystallogr D Struct Biol. 2020 May 1;76(Pt 5):458-471. doi: 10.1107/S2059798320004027. Epub 2020 Apr 23.
7
The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1.结核分枝杆菌ClpP1P2蛋白酶与其ATP酶伴侣ClpX和ClpC1发生不对称相互作用。
PLoS One. 2015 May 1;10(5):e0125345. doi: 10.1371/journal.pone.0125345. eCollection 2015.
8
The unfoldase ClpC1 of regulates the expression of a distinct subset of proteins having intrinsically disordered termini. unfoldase ClpC1 调控具有固有无序末端的一组独特蛋白的表达。
J Biol Chem. 2020 Jul 10;295(28):9455-9473. doi: 10.1074/jbc.RA120.013456. Epub 2020 May 14.
9
Mutation analysis of the interactions between Mycobacterium tuberculosis caseinolytic protease C1 (ClpC1) and ecumicin.结核分枝杆菌组织蛋白酶 C1(ClpC1)与埃库霉素相互作用的突变分析。
Int J Biol Macromol. 2017 Aug;101:348-357. doi: 10.1016/j.ijbiomac.2017.03.126. Epub 2017 Mar 22.
10
Antibacterial peptide CyclomarinA creates toxicity by deregulating the Mycobacterium tuberculosis ClpC1-ClpP1P2 protease.抗菌肽环马菌素 A 通过使结核分枝杆菌 ClpC1-ClpP1P2 蛋白酶失活来产生毒性。
J Biol Chem. 2022 Aug;298(8):102202. doi: 10.1016/j.jbc.2022.102202. Epub 2022 Jun 26.

引用本文的文献

1
Total Synthesis of Mycoplanecin A.霉菌平面霉素A的全合成
Org Lett. 2025 Aug 15;27(32):9061-9065. doi: 10.1021/acs.orglett.5c02803. Epub 2025 Aug 1.
2
Total Syntheses of Stereoisomeric Congeners of Rufomycin Natural Products Having Anti-Mycobacterial Activity.具有抗分枝杆菌活性的鲁佛霉素天然产物立体异构体同系物的全合成。
Org Lett. 2025 Jun 20;27(24):6342-6348. doi: 10.1021/acs.orglett.5c01525. Epub 2025 Jun 6.
3
Diversity of secondary metabolites from marine Streptomyces with potential anti-tubercular activity: a review.

本文引用的文献

1
Antibacterial peptide CyclomarinA creates toxicity by deregulating the Mycobacterium tuberculosis ClpC1-ClpP1P2 protease.抗菌肽环马菌素 A 通过使结核分枝杆菌 ClpC1-ClpP1P2 蛋白酶失活来产生毒性。
J Biol Chem. 2022 Aug;298(8):102202. doi: 10.1016/j.jbc.2022.102202. Epub 2022 Jun 26.
2
Semi-Synthesis of Marine-Derived Ilamycin F Derivatives and Their Antitubercular Activities.海洋来源的伊拉霉素F衍生物的半合成及其抗结核活性。
Front Chem. 2021 Oct 29;9:774555. doi: 10.3389/fchem.2021.774555. eCollection 2021.
3
Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments.
具有潜在抗结核活性的海洋链霉菌次级代谢产物的多样性:综述
Arch Microbiol. 2025 Feb 17;207(3):64. doi: 10.1007/s00203-024-04233-8.
4
Rapid Peptide Cyclization Inspired by the Modular Logic of Nonribosomal Peptide Synthetases.受非核糖体肽合成酶模块化逻辑启发的快速肽环化
J Am Chem Soc. 2024 Jun 6;146(24):16787-801. doi: 10.1021/jacs.4c04711.
5
Steglich esterification: A versatile synthetic approach toward the synthesis of natural products, their analogues/derivatives.施陶丁格酯化反应:一种用于合成天然产物及其类似物/衍生物的通用合成方法。
Heliyon. 2023 Dec 9;10(1):e23416. doi: 10.1016/j.heliyon.2023.e23416. eCollection 2024 Jan 15.
6
Recent Advances in Polypeptide Antibiotics Derived from Marine Microorganisms.海洋微生物来源的多肽抗生素研究进展。
Mar Drugs. 2023 Oct 22;21(10):547. doi: 10.3390/md21100547.
红曲霉素或伊拉霉素:命名澄清和明确的结构归属。
J Nat Prod. 2021 Oct 22;84(10):2644-2663. doi: 10.1021/acs.jnatprod.1c00198. Epub 2021 Oct 10.
4
Hit-optimization using target-directed dynamic combinatorial chemistry: development of inhibitors of the anti-infective target 1-deoxy-d-xylulose-5-phosphate synthase.利用靶向动态组合化学进行的命中优化:抗感染靶点1-脱氧-D-木酮糖-5-磷酸合酶抑制剂的开发。
Chem Sci. 2021 Apr 28;12(22):7775-7785. doi: 10.1039/d1sc00330e.
5
Biosynthetic Interrogation of Soil Metagenomes Reveals Metamarin, an Uncommon Cyclomarin Congener with Activity against .生物合成对土壤宏基因组的研究揭示了 Metamarin,一种具有抗活性的不常见环马啉同系物。
J Nat Prod. 2021 Apr 23;84(4):1056-1066. doi: 10.1021/acs.jnatprod.0c01104. Epub 2021 Feb 23.
6
Marine natural products.海洋天然产物。
Nat Prod Rep. 2021 Mar 4;38(2):362-413. doi: 10.1039/d0np00089b.
7
Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors.蓝藻作为天然疗法和药物潜力:在抗肿瘤活性和作为纳米载体中的作用。
Molecules. 2021 Jan 5;26(1):247. doi: 10.3390/molecules26010247.
8
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes.海洋抗癌药物:概述及其化学类别特别关注。
Mar Drugs. 2020 Dec 4;18(12):619. doi: 10.3390/md18120619.
9
ClpL is a functionally active tetradecameric AAA+ chaperone, distinct from hexameric/dodecameric ones.ClpL 是一种具有功能活性的十四聚体 AAA+ 伴侣蛋白,有别于六聚体/十二聚体。
FASEB J. 2020 Nov;34(11):14353-14370. doi: 10.1096/fj.202000843R. Epub 2020 Sep 10.
10
Tackling antimicrobial resistance by exploring new mechanisms of antibiotic action.通过探索抗生素作用的新机制来应对抗菌药物耐药性。
Future Microbiol. 2020 Jun;15:703-708. doi: 10.2217/fmb-2020-0048. Epub 2020 Jul 10.